Biogen

Biogen

Organization

Heard in 19 episodes across 12 shows since Apr 2026

Biogen Inc. is a publicly traded American biotechnology company headquartered in Cambridge, Massachusetts, focused primarily on discovering, developing, and commercializing medicines for neurological and neurodegenerative diseases. The podcast references describe Biogen in that core context: its Alzheimer’s tau-focused drug research, partnerships such as a neurology collaboration with City Therapeutics, and its broader role as a major biopharmaceutical company; one market segment also refers to its stock under the ticker BIIB.

Discussed inMarkets75%AI & Tech25%

Episodes

19
across 12 shows

This week

0
episodes on 0 shows

Expert statements

6
5 positive · 1 negative

Share of the conversation

Mentions of Biogen per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.

0.0‰0.02‰0.04‰0.06‰Aug 25Sep 16Oct 9Oct 31Nov 22
Show the data
DayShare (7-day)Mentions
Sep 70.01‰1
Sep 220.03‰3
Oct 60.01‰1
Oct 70.02‰1
Oct 160.02‰2
Oct 200.03‰1
Oct 210.03‰1
Oct 230.02‰1
Oct 280.02‰1
Nov 20.02‰1
Nov 60.02‰1
Nov 200.01‰1

The full trend: rank, tone and why it is trending →

Email alert

Email me when Biogen comes up on a podcast

One email a week at most, with the new episodes that mention Biogen. Free, no account needed, unsubscribe in one click.

What experts have said about Biogen

6 statements · 5 positive · 1 negative

  1. David SekeraNegativeNov 2, 2026· The Morning Filter

    Investors should consider taking profits on Biogen.

    “maybe now is a good time to at least take some of those profits off the table”

    Listen at 22:05

    Open the episode · 3 Stocks to Sell and 3 Stocks to Buy for November
  2. Biogen’s chart remains potentially actionable after reclaiming its buy point.

    “the chart's not broken, I'm going to say this is still potentially actionable.”

    Listen at 17:27

    Open the episode · Chips Send Nasdaq To New Highs; Micron, Shopify, Biogen In Focus
  3. Biogen is among the stronger individual medical stocks and is actionable.

    “I think Biogen is right up there in terms of that, you know, retaking that buy point to me does make it actionable.”

    Listen at 18:52

    Open the episode · Chips Send Nasdaq To New Highs; Micron, Shopify, Biogen In Focus

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

19 episodes featuring Biogen, newest first